CLINICAL_TRIALS trial_result · 2012-12-18

Clinical Trial Update: A Study of V950 in People With Alzheimer Disease (V950-001 AM7) [Phase 1]

Phase 1 results from a Merck-sponsored study of V950 in people with Alzheimer's disease; the trial has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED | Results posted: 2012-12-18